These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8621403)

  • 1. The interleukin-6 (IL-6) partial antagonist (Q159E,T162P)IL-6 interacts with the IL-6 receptor and gp130 but fails to induce a stable hexameric receptor complex.
    Hammacher A; Simpson RJ; Nice EC
    J Biol Chem; 1996 Mar; 271(10):5464-73. PubMed ID: 8621403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The N-terminus of gp130 is critical for the formation of the high-affinity interleukin-6 receptor complex.
    Moritz RL; Ward LD; Tu GF; Fabri LJ; Ji H; Yasukawa K; Simpson RJ
    Growth Factors; 1999; 16(4):265-78. PubMed ID: 10427501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of interleukin-6 (IL-6) dimerization on formation of the high affinity hexameric IL-6.receptor complex.
    Ward LD; Hammacher A; Howlett GJ; Matthews JM; Fabri L; Moritz RL; Nice EC; Weinstock J; Simpson RJ
    J Biol Chem; 1996 Aug; 271(33):20138-44. PubMed ID: 8702737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.
    Müller-Newen G; Küster A; Hemmann U; Keul R; Horsten U; Martens A; Graeve L; Wijdenes J; Heinrich PC
    J Immunol; 1998 Dec; 161(11):6347-55. PubMed ID: 9834125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses.
    Jostock T; Müllberg J; Ozbek S; Atreya R; Blinn G; Voltz N; Fischer M; Neurath MF; Rose-John S
    Eur J Biochem; 2001 Jan; 268(1):160-7. PubMed ID: 11121117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High affinity interleukin-6 receptor is a hexameric complex consisting of two molecules each of interleukin-6, interleukin-6 receptor, and gp-130.
    Ward LD; Howlett GJ; Discolo G; Yasukawa K; Hammacher A; Moritz RL; Simpson RJ
    J Biol Chem; 1994 Sep; 269(37):23286-9. PubMed ID: 8083235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor engagement by viral interleukin-6 encoded by Kaposi sarcoma-associated herpesvirus.
    Aoki Y; Narazaki M; Kishimoto T; Tosato G
    Blood; 2001 Nov; 98(10):3042-9. PubMed ID: 11698289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A complex of the soluble interleukin-6 receptor and interleukin-6 is internalized via the signal transducer gp130.
    Graeve L; Korolenko TA; Hemmann U; Weiergräber O; Dittrich E; Heinrich PC
    FEBS Lett; 1996 Dec; 399(1-2):131-4. PubMed ID: 8980136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncostatin M binds directly to gp130 and behaves as interleukin-6 antagonist on a cell line expressing gp130 but lacking functional oncostatin M receptors.
    Sporeno E; Paonessa G; Salvati AL; Graziani R; Delmastro P; Ciliberto G; Toniatti C
    J Biol Chem; 1994 Apr; 269(15):10991-5. PubMed ID: 8157624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6 receptor signaling. I. gp80 and gp130 receptor interaction in the absence of interleukin-6.
    Gaillard JP; Mani JC; Liautard J; Klein B; Brochier J
    Eur Cytokine Netw; 1999 Mar; 10(1):43-8. PubMed ID: 10210772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of recombinant soluble IL-6-signal transducer, gp130, with a complex of IL 6 and soluble IL-6 receptor, and establishment of an ELISA for soluble gp130.
    Yasukawa K; Futatsugi K; Saito T; Yawata H; Narazaki M; Suzuki H; Taga T; Kishimoto T
    Immunol Lett; 1992 Feb; 31(2):123-30. PubMed ID: 1740350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth.
    Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
    Int Immunol; 1996 Apr; 8(4):595-602. PubMed ID: 8722639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 (IL-6) antagonism by soluble IL-6 receptor alpha mutated in the predicted gp130-binding interface.
    Salvati AL; Lahm A; Paonessa G; Ciliberto G; Toniatti C
    J Biol Chem; 1995 May; 270(20):12242-9. PubMed ID: 7744875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a biosensor with surface plasmon resonance detection for the determination of binding constants: measurement of interleukin-6 binding to the soluble interleukin-6 receptor.
    Ward LD; Howlett GJ; Hammacher A; Weinstock J; Yasukawa K; Simpson RJ; Winzor DJ
    Biochemistry; 1995 Mar; 34(9):2901-7. PubMed ID: 7893704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular modeling-guided mutagenesis of the extracellular part of gp130 leads to the identification of contact sites in the interleukin-6 (IL-6).IL-6 receptor.gp130 complex.
    Horsten U; Müller-Newen G; Gerhartz C; Wollmer A; Wijdenes J; Heinrich PC; Grötzinger J
    J Biol Chem; 1997 Sep; 272(38):23748-57. PubMed ID: 9295319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The balance of interleukin (IL)-6, IL-6·soluble IL-6 receptor (sIL-6R), and IL-6·sIL-6R·sgp130 complexes allows simultaneous classic and trans-signaling.
    Baran P; Hansen S; Waetzig GH; Akbarzadeh M; Lamertz L; Huber HJ; Ahmadian MR; Moll JM; Scheller J
    J Biol Chem; 2018 May; 293(18):6762-6775. PubMed ID: 29559558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global and local determinants for the kinetics of interleukin-4/interleukin-4 receptor alpha chain interaction. A biosensor study employing recombinant interleukin-4-binding protein.
    Shen BJ; Hage T; Sebald W
    Eur J Biochem; 1996 Aug; 240(1):252-61. PubMed ID: 8797861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a soluble IL-6 receptor alpha mutant C277D/H280I expressed in E.coli.
    Duan J; Wang J; Cai X; Wang L; Liu H; Zou M
    Biochem Mol Biol Int; 1997 May; 41(6):1101-8. PubMed ID: 9161704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble gp130 is up-regulated in the implantation window and shows altered secretion in patients with primary unexplained infertility.
    Sherwin JR; Smith SK; Wilson A; Sharkey AM
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3953-60. PubMed ID: 12161539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of immobilized synthetic peptides for the identification of contact sites between human interleukin-6 and its receptor.
    Weiergräber O; Schneider-Mergener J; Grötzinger J; Wollmer A; Küster A; Exner M; Heinrich PC
    FEBS Lett; 1996 Jan; 379(2):122-6. PubMed ID: 8635575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.